Search Results - "Abduloeva, N. Kh"

Opsoclonus-myoclonus-ataxia syndrome as a complication of pembrolizumab treatment in an adult patient (a case report and literature review) by Rumiantseva, K. A., Polushin, A. Yu, Abduloeva, N. Kh, Skiba, Ya. B., Moiseenko, V. M.

“…Background. Opsoclonus-myoclonus-ataxia syndrome (OMAS) in adults is an extremely rare condition, often leading to rapidly deteriorated neurological…”
Get full text

Incidence of Synchronous Multiple Primary Melanoma in Patients with Solitary Melanoma: a Prospective Comparative Study by Egorenkov, V. V., Moiseenko, F. V., Volkov, N. M., Molchanov, M. S., Ravkina, M. S., Abduloeva, N. Kh, Linets, A. V., Khairutdinov, V. R., Aksenov, M. S., Moiseyenko, V. M.

“…Background. Malignant melanoma is steadily exaggerating over the recent decades. Nonetheless, improved systemic therapies have substantially increased life…”
Get full text

Efficacy of Videoendoscopic Inguinal Femoral Lymphadenectomy for Management of Metastatic Skin Melanoma by Egorenkov, V. V., Moiseenko, F. V., Volkov, N. M., Molchanov, M. S., Ravkina, M. S., Abduloeva, N. Kh, Linets, A. V., Khairutdinov, V. R., Ibragimov, A. M., Moiseyenko, V. M.

“…Aim. Assessment of the utility and advantage of videoendoscopic inguinal femoral lymphadenectomy (VE-LAD) over the standard open technique (OLAD) in patients…”
Get full text

Comprehensive Screening for COVID-19 at St. Petersburg Oncology Centre by Volkov, N. M., Lebedeva, M. S., Egorenkov, V. V., Moiseenko, F. V., Abduloeva, N. Kh, Bogdanov, A. A., Terterov, I. N., Chernobrivceva, V. V., Valeeva, N. E., Myasnikova, E. B., Navatskaya, A. S., Bogdanov, A. A., Moiseyenko, V. M.

“…Background. Clinical reports on the coronavirus disease 2019 (COVID-19) suggest its higher incidence and worse outcomes in cancer patients. Considering a rapid…”
Get full text

Toxicity and efficacy of biosimilar bevacizumab in the second-line therapy for metastatic colon cancer in routine clinical practice: results of an independent observational study by M.   Yu. Fedyanin, F.   V. Moiseenko, M.   A. Lyadova, V.  N.  Vorobyeva, V.  V.  Petkau, A.  V.  Fateeva, E.  S.  Kuzmina, O.  Yu.  Novikova, V.   A. Chubenko, N.  Kh.  Abduloeva, A.  A.  Kudryavtsev, E.   O. Ignatova, R.   R. Shakirov, O.  A.  Pardabekova, L.  V.  Kindyalova, S.  P.  Pelikh, O.   A. Gladkov, S.  A.  Tjulandin, A.  A.  Tryakin

“…Objective: to compare the efficacy and tolerability of second‑line chemotherapy with original bevacizumab (Avastin) and biosimilar bevacizumab produced by…”
Get full text

Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test by Stepanova, M. L., Kuznetsovа, O. A., Shilo, P. S., Moiseenko, F. V., Abduloeva, N. Kh, Artemyeva, E. V., Zhabina, A. S., Kramchaninov, M. M., Volkov, N. M., Pokataev, I. A., Rumyantsev, A. A., Plaksa, I. L., Gairyan, M. A., Isaev, A. A., Ivanov, M. V., Sadykova, Yu. F., Mileiko, V. A., Shamrikova, V. V., Ledin, E. V., Tryakin, A. A., Fedyanin, M. Yu

“…Background. The use of targeted sequencing panels makes it possible to optimize and personalize the treatment strategy for cancer patients. Given the lack of a…”
Get full text

The long-term clinical efficacy and safety of lenvatinib plus pembrolizumab in endometrial cancer: data from routine clinical practice in Russia by Protasova, A. E., Rumyantsev, A. A., Sheremet, M. Yu, Goryainova, A. Yu, Volkonsky, M. V., Kedrova, A. G., Kuzmicheva, S. V., Aymamedova, O. N., Musaeva, Kh. S., Soroka, S. M., Romanchuk, O. V., Orlova, V. N., Graft, N. G., Ibragimova, M. R., Merzlikina, Yu. I., Stepura, L. V., Tatulova, L. B., Abasova, A. A., Akopyan, A. A., Arsenyeva, E. V., Vasilyeva, Yu. V., Belonogov, A. V., Krivolapova, L. V., Bobryshev, A. A., Vovk, D. Yu, Luev, I. A., Abidova, N. R., Zhikhorev, R. S., Zhelezkova, T. A., Grigoryan, T. T., Makarkina, T. A., Ekimov, V. A., Zhizhina, A. V., Karabina, E. V., Kuchevskaya, O. A., Filippova, V. M., Linchenko, T. A., Lisaeva, A. A., Fedorova, A. N., Maystrenko, K. S., Markizova, E. V., Kogay, E. V., Krasnorutskaya, E. P., Popova, M. E., Pchelin, Yu. Yu, Ryanzhina, R. A., Sidorov, D. B., Shakhnovich, E. B., Alekseev, S. M., Zinkevich, M. V., Belogortsev, I. O., Chubenko, V. A., Moiseenko, V. M., Abduloeva, N. Kh, Lebedinets, A. A., Strakh, L. V., Semenov, L. K., Bolieva, M. B., Aydaeva, F. Z.

“…Background. Endometrial cancer (EC) treatment outcomes need to be improved. Immunotargeted therapy lead to long-term and delayed effects compared to…”
Get full text

Efficacy and safety of lenvatinib and pembrolizumab in the treatment of endometrial cancer: data from routine clinical practice in Russia by Rumyantsev, A. A., Protasova, A. E., Sheremet, M. Yu, Goryainova, A. Yu, Volkonskiy, M. V., Kedrova, A. G., Kuzmicheva, S. V., Aymamedova, O. N., Musaeva, Kh. S., Soroka, S. M., Romanchuk, O. V., Orlova, V. N., Graft, N. G., Ibragimova, M. R., Merzlikina, Yu. I., Stepura, L. V., Tatulova, L. B., Abasova, A. A., Akopyan, A. A., Arsenyeva, E. V., Vasilyeva, Yu. V., Belonogov, A. V., Krivolapova, L. V., Bobryshev, A. A., Vovk, D. Yu, Luev, I. A., Abidova, N. R., Zhikhorev, R. S., Zhelezkova, T. A., Grigoryan, T. T., Makarkina, T. A., Ekimov, V. A., Zhizhina, A. V., Karabina, E. V., Kuchevskaya, O. A., Filippova, V. M., Linchenko, T. A., Lisaeva, A. A., Fedorova, A. N., Maystrenko, K. S., Markizova, E. V., Kogay, E. V., Krasnorutskaya, E. P., Popova, M. E., Pchelin, Yu. Yu, Ryanzhina, R. A., Sidorov, D. B., Shakhnovich, E. B., Alekseev, S. M., Zinkevich, M. V., Belogortsev, I. O., Chubenko, V. A., Moiseenko, V. M., Abduloeva, N. Kh, Lebedinets, A. A., Strakh, L. V., Semenov, L. K., Bolieva, M. B., Aydaeva, F. Z.

“…Aim . To assess the efficacy and safety of lenvatinib and pembrolizumab for the treatment of mismatch repair-proficient endometrial cancer (EC) in routine…”
Get full text

Investigation of hepatoprotector Metrop GP influence on tumor growth or antitumor action of doxorubicin by Abduloeva, N Kh, Stukov, A N, Moiseenko, V M

“…An experimental model of solid tumor of Ehrlich failed to reveal any influence of the hepatoprotector Metrop GP on tumor growth or affect antitumor action of…”
Get more information

Therapeutic activity of gemcitabine in intracranial tumors by Stukov, A N, Filatova, L V, Latipova, D Kh, Bespalov, V G, Belyaeva, O A, Kireeva, G S, Vasilieva, I N, Alexandrov, V A, Maidin, M A, Semenov, A L, Vershinina, S F, Markochev, A B, Abduloeva, N Kh, Chubenko, V A, Semiglazova, T Yu

“…Gemcitabine is known to exert a therapeutic effect on brain tumors despite the limited permeability of the blood-brain barrier (BBB). In our experimental…”
Get more information

Preclinical evaluation of the effect of Metrop GP on acute toxicity and hepatotoxicity of chemotherapy by Abduloeva, N Kh, Kolbasov, S E, Stukov, A N, Moiseenko, V M

“…Our paper presents the results of preclinical evaluation of the mitigating effect of Metrop GP on the acute toxicity and hepatotoxicity induced by paclitaxel…”
Get more information

Rol' gefitiniba v lechenii bol'nykhnemelkokletochnym rakom legkogos mutatsiey v gene retseptoraepidermal'nogo faktora rosta by F V Moiseenko, E N Imyanitov, D E Matsko, I I Semenov, E V Levchenko, V M Moiseenko, C A Protsenko, V A Chubenko, N V Brezhnev, A G Ievleva, A O Ivantsov, N Kh Abduloeva

Get full text